Pembrolizumab vs Sitagliptin

## Pembrolizumab vs Sitagliptin: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Sitagliptin**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

**Sitagliptin**: DPP-4 inhibitor increasing incretin levels.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Sitagliptin — 12.4 hours.

## Chemical Properties

**Molecular Formula**: Pembrolizumab — N/A; Sitagliptin — C16H15F6N5O.

**Molecular Weight**: Pembrolizumab — N/A; Sitagliptin — 407.3140 g/mol.

**Type**: Pembrolizumab — Antibody; Sitagliptin — Small molecule.